Giammanco, Antonina
 Distribuzione geografica
Continente #
NA - Nord America 4.295
EU - Europa 2.119
AS - Asia 1.936
Continente sconosciuto - Info sul continente non disponibili 438
SA - Sud America 354
AF - Africa 68
OC - Oceania 7
Totale 9.217
Nazione #
US - Stati Uniti d'America 4.147
SG - Singapore 746
RU - Federazione Russa 697
IT - Italia 573
CN - Cina 389
BR - Brasile 284
VN - Vietnam 205
HK - Hong Kong 189
DE - Germania 153
PL - Polonia 140
BD - Bangladesh 105
GB - Regno Unito 100
FI - Finlandia 98
FR - Francia 95
CA - Canada 79
IN - India 56
JP - Giappone 52
IE - Irlanda 45
MX - Messico 31
NL - Olanda 31
AT - Austria 29
IQ - Iraq 26
TR - Turchia 26
ES - Italia 24
AR - Argentina 23
SE - Svezia 23
BE - Belgio 22
KR - Corea 21
PK - Pakistan 18
RO - Romania 18
UA - Ucraina 15
ZA - Sudafrica 15
EC - Ecuador 14
ID - Indonesia 13
GR - Grecia 12
KE - Kenya 12
SA - Arabia Saudita 11
IR - Iran 9
DZ - Algeria 8
MA - Marocco 8
MY - Malesia 8
TW - Taiwan 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CO - Colombia 6
CR - Costa Rica 6
IL - Israele 6
JM - Giamaica 6
LT - Lituania 6
PE - Perù 6
PT - Portogallo 6
UY - Uruguay 6
AU - Australia 5
CH - Svizzera 5
CL - Cile 5
EG - Egitto 5
HU - Ungheria 5
PA - Panama 5
PH - Filippine 5
TT - Trinidad e Tobago 5
VE - Venezuela 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
HN - Honduras 4
NP - Nepal 4
RS - Serbia 4
BO - Bolivia 3
CY - Cipro 3
KZ - Kazakistan 3
SN - Senegal 3
AO - Angola 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
GT - Guatemala 2
HR - Croazia 2
MM - Myanmar 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PY - Paraguay 2
RE - Reunion 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TG - Togo 2
TH - Thailandia 2
BG - Bulgaria 1
BH - Bahrain 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
HT - Haiti 1
JO - Giordania 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LB - Libano 1
Totale 8.767
Città #
Ashburn 585
Singapore 493
San Jose 413
Chandler 322
Fairfield 268
Hong Kong 181
Houston 168
Seattle 151
Woodbridge 131
Moscow 123
New York 123
Zgierz 115
Council Bluffs 114
Wilmington 102
Cambridge 99
Palermo 93
Beijing 79
Los Angeles 77
Medford 64
Ho Chi Minh City 61
Ann Arbor 58
Altamura 54
Hanoi 53
Lauterbourg 52
Dallas 51
Santa Clara 48
Tokyo 48
Chicago 43
Dublin 42
Des Moines 41
Princeton 40
Lawrence 38
Rome 37
London 33
Milan 32
Buffalo 31
Toronto 30
Boardman 29
Helsinki 28
San Diego 28
São Paulo 24
Hefei 23
Nanjing 22
Memphis 21
Brussels 20
Chennai 20
The Dalles 20
Frankfurt am Main 19
Orem 19
Lappeenranta 18
Ludwigshafen am Rhein 18
Bremen 17
Venice 17
Denver 16
Haiphong 16
Warsaw 16
Montreal 15
Munich 15
Naples 15
Phoenix 14
Atlanta 13
Jinan 11
Nairobi 11
Brooklyn 10
Guangzhou 10
Johannesburg 10
Nuremberg 10
Philadelphia 10
Shenyang 10
Baghdad 9
Biên Hòa 9
Boston 9
Da Nang 9
Hebei 9
Mexico City 9
Nanchang 9
Tianjin 9
Vienna 9
Amsterdam 8
Bologna 8
Changsha 8
Dearborn 8
Falkenstein 8
Izmir 8
Lahore 8
Paris 8
Stockholm 8
Belo Horizonte 7
Cagliari 7
Miami 7
Rio de Janeiro 7
Tashkent 7
Turin 7
Wakefield 7
Charlotte 6
Erbil 6
Favara 6
Guarulhos 6
Manchester 6
Salt Lake City 6
Totale 5.276
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 286
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 282
Resting energy expenditure and substrate oxidation in malnourished patients with type 1 glycogenosis 276
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred 273
REDUCTION OF CHOLESTEROL WITH NUTRACEUTICAL: RESULTS OF A DOUBLE BLIND STUDY 270
Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population 261
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome 260
Genotypic and phenotypic characterization of patients with autosomal dominant hypercholesterolemia in sicily 241
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing 230
Albumin versus solvent/detergent-treated pooled plasma as replacement fluid for long-term plasma exchange therapy in a patient with primary hypertriglyceridemia and recurrent hyperlipidemic pancreatitis 229
Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia 204
Heterogenous forms of dyslipidemiain women with polycystic ovary syndrome 203
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography 199
Anti-PCSK9 treatment: Is ultra-low LDL always good? 189
Liver and statins: a critical appraisal of the evidence 187
Is echocardiography mandatory for patients with chronic kidney disease? 182
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 173
PULMONARY EMBOLISM IN AN EMERGENCY CARE UNIT: EVALUATION OF PREDICTIVE FACTORS FROM CLINICAL HISTORY AND PHYSICAL EXAM 166
An unusual case of chronic diarrhea: a case report 165
The pathophysiology of intestinal lipoprotein production 161
Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients 159
DeepSRE: Identification of sterol responsive elements and nuclear transcription factors Y proximity in human DNA by Convolutional Neural Network analysis 155
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism 149
Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases 149
Comparison of two polygenic risk score to identify non-monogenic primary hypocholesterolemias in a large cohort of Italian hypocholesterolemic subjects 148
Valutazione in vivo dello stress ossidativo e dell'attivazione piastrinica nell'ipobetalipoproteinemia familiare: confronto con l'ipercolesterolemia familiare e l'iperalfalipoproteinemia familiare 144
PCSK9-D374Y MEDIATED LDL-R DEGRADATION CAN BE FUNCTIONALLY INHIBITED BY EGF-A AND TRUNCATED EGF-A PEPTIDES. AN IN VITRO STUDY 142
FISIOPATOLOGIA DELLA SINTESI DELLE LIPOPROTEINE INTESTINALI 140
Correlations Between Novel Adiposity Indices and Electrocardiographic Evidence of Left Ventricular Hypertrophy in Individuals with Arterial Hypertension 139
MUTATION IN CANDIDATE GENES ACCOUNT FOR A SMALL MINORITY OF HYPOBETALIPOPROTEINEMIAS AND NGS ANALYSIS SUPPORT POLYGENICITY IN MUTATION-NEGATIVE PATIENTS 139
PREVALENCE OF STATIN INTOLERANCE IN A COHORT OF OUTPATIENTS IN A LIPID CLINIC 139
Therapeutic options for homozygous familial hypercholesterolemia: the role of Lomitapide 138
MOLECULAR CHARACTERIZATION OF PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE WITH "EXTREME LDL-C PHENOTYPES" 136
Do genetically determined very high and very low LDL levels contribute to Lp(a) plasma concentration? 134
Resistive index of ophthalmic artery as an imaging biomarker of hypertension-related vascular and kidney damage 132
EFFICACY AND SAFETY OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: THE PAN-EUROPEAN RETROSPECTIVE OBSERVATIONAL STUDY 130
Statin-induced autoimmune myositis: a proposal of an "experience-based" diagnostic algorithm from the analysis of 69 patients 124
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 122
IDENTIFICATION OF P.LEU167DEL APOE GENE MUTATION BY NEXT GENERATION SEQUENCING IN A LARGE HYPERCHOLESTEROLEMIC FAMILY 122
EFFECTIVENESS AND SAFETY OF LOMITAPIDE IN A PATIENT WITH FAMILIAL CHYLOMICRONEMIA SYNDROME 120
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation 116
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome 116
Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial 113
Derivation and validation of a predictive mortality model of in-hospital patients with Acinetobacter baumannii nosocomial infection or colonization 112
Echocardiographic Calcium Score of Aortic Valve Correlates with Coronary Artery Calcium Score in Heterozygous Familial Hypercholesterolemia 108
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 103
Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study 99
Lack of phenotypic additive effect of familial defective apolipoprotein B3531 in familial hypercholesterolaemia 97
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 89
Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access program 88
Erdheim-Chester disease as complex clinical presentation and diagnosis: A case report and concise review of literature 81
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 80
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 80
Coronary Artery Calcium Is Independently Associated with Arterial Stiffness and LDL Cholesterol Burden in Patients with Familial Hypercholesterolemia 79
Clinical and Biochemical Characterization of Fabry Disease Associated GLA Gene Variants: Data From a Large Cohort of 469 Thousand Genotyped Subjects of the UK Biobank Database 73
Intestinal epithelial HuR modulates distinct pathways of proliferation and apoptosis and attenuates small intestinal and colonic tumor development. 71
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 69
THE ROLE OF TRANSIENT ELASTOGRAPHY IN NAFLD 68
Six genetic variants are associated with cardiovascular disease independently from canonical risk factors: a new method to refine GWAS results based on the UKBiobank phenotype database 63
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 62
Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition 55
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 45
Prescribing cascades among hospitalized older adults: a retrospective cohort study from the REPOSI registry 43
Unnecessary use of proton pump inhibitors in patients discharged on oral anticoagulant therapy: data from the REPOSI registry 38
Echocardiographic Red Flags in Wild-Type Transthyretin Amyloidosis: Sex-Specific Gaps for Wall Thickness and Left Ventricular Mass 25
Real-world management of familial hypercholesterolemia in paediatric patients: a 3-year follow-up from the LIPIGEN registry 24
Neutrophil-lymphocyte ratio is associated with worse outcomes in patients with cirrhosis: insights from the PRO-LIVER Registry 17
null 4
Resistive index of ophthalmic artery as an imaging biomarker of hypertension-related vascular and kidney damage 1
Totale 9.217
Categoria #
all - tutte 35.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022410 0 0 0 6 6 17 20 31 59 111 44 116
2022/2023903 74 174 31 116 67 138 37 79 110 10 33 34
2023/2024494 18 64 46 59 23 127 39 29 9 20 16 44
2024/20251.036 19 90 55 68 40 48 75 85 82 136 155 183
2025/20263.897 299 158 192 310 385 588 541 425 283 243 264 209
2026/2027861 218 113 452 78 0 0 0 0 0 0 0 0
Totale 9.217